Neoadjuvant chemotherapy response in androgen receptor-positive triple-negative breast cancer: potential predictive biomarkers and genetic alterations

Abstract Background The aim of the present study was to investigate whether the androgen receptor (AR) status affects the efficacy of neoadjuvant chemotherapy (NACT) in triple negative breast cancer (TNBC) patients, and to elucidate the predictive biomarkers and mutations associated with pathologica...

Full beskrivning

Bibliografiska uppgifter

Huvudupphov:	Ming Li, Shuling Zhou, Hong Lv, Mengyuan Cai, Ruohong Shui, Wentao Yang
Materialtyp:	Artigo
Språk:	Inglês
Utgiven:	BMC 2025-03-01
Serie:	Breast Cancer Research
Ämnen:	Androgen receptor Neoadjuvant chemotherapy Predictive biomarkers Genetic alterations
Länkar:	https://doi.org/10.1186/s13058-025-01994-y
Taggar:	Lägg till en tagg Inga taggar, Lägg till första taggen!